[ad_1]
—Program will probably be airing on PBS with Dennis Quaid in April
—It would even be seen on Fox Enterprise Community
MARLBOROUGH, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Phio Prescribed drugs Corp. (Nasdaq: PHIO), a scientific stage biotechnology firm whose proprietary INTASYL™ siRNA gene silencing know-how is designed to make immune cells simpler in killing tumor cells, at this time introduced its INTASYL platform would be the focus of Viewpoint, a nationwide program hosted by Dennis Quaid. This system will air in April on PBS stations throughout the nation.
The highlight can even be featured nationally on Fox Enterprise Community on April 24th, and regionally on a lot of networks, together with CNN and MSNBC, all through the month of April.
About Phio Prescribed drugs Corp.
Phio Prescribed drugs Corp. (Nasdaq: PHIO) is a scientific stage biotechnology firm whose proprietary INTASYL™ siRNA gene silencing know-how is designed to make immune cells simpler in killing tumor cells. INTASYL is the one self-delivering RNAi know-how centered on immuno-oncology therapeutics. INTASYL medicine exactly goal particular proteins that scale back the physique’s skill to battle most cancers, with out the necessity for specialised formulations or drug supply techniques.
For extra info, go to the Firm’s web site, www.phiopharma.com.
Ahead Wanting Statements
This press launch incorporates forward-looking statements inside the which means of the Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements will be recognized by phrases similar to “intends,” “believes,” “anticipates,” “signifies,” “plans,” “expects,” “suggests,” “might,” “would,” “ought to,” “potential,” “designed to,” “will,” “ongoing,” “estimate,” “forecast,” “goal,” “predict,” “might” and comparable references, though not all forward-looking statements include these phrases. These statements are based mostly solely on our present beliefs, expectations and assumptions and are topic to inherent uncertainties, dangers and adjustments in circumstances which might be troublesome to foretell and lots of of that are exterior of our management. Our precise outcomes might differ materially from these indicated within the forward-looking statements because of a lot of essential components, together with, however not restricted to, the influence to our enterprise and operations by inflationary pressures, rising rates of interest, recession fears, the event of our product candidates, outcomes from our preclinical and scientific actions, our skill to execute on enterprise methods, our skill to develop our product candidates with collaboration companions, and the success of any such collaborations, the timeline and length for advancing our product candidates into scientific growth, the timing or probability of regulatory filings and approvals, the success of our efforts to commercialize our product candidates if permitted, our skill to fabricate and provide our product candidates for scientific actions, and for business use if permitted, the scope of safety we’re in a position to set up and keep for mental property rights overlaying our know-how platform, our skill to acquire future financing, market and different circumstances and people recognized in our Annual Report on Type 10-Okay and subsequent Quarterly Studies on Type 10-Q underneath the caption “Danger Elements” and in different filings the Firm periodically makes with the SEC. Readers are urged to assessment these threat components and to not act in reliance on any forward-looking statements, as precise outcomes might differ from these contemplated by our forward-looking statements. Phio doesn’t undertake to replace forward-looking statements to replicate a change in its views, occasions or circumstances that happen after the date of this launch, besides as required by regulation.
Contact:
Phio Prescribed drugs Corp.
[email protected]
PR Contact
Michael Adams
Bridge View Media
[email protected]
[ad_2]
Source link
